Sialic acid surface decoration enhances cellular uptake and apoptosis-inducing activity of selenium nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 83, Issue 1, 2011, Pages 183-187

  Zheng, Jun Sheng ^a   Zheng, Shan Yuan ^b,c   Zhang, Yi Bo ^b   Yu, Bo ^b   Zheng, Wenjie ^b   Yang, Fang ^b   Chen, Tianfeng ^b,d  

^a SUN YAT SEN UNIVERSITY   (China)

^b JINAN UNIVERSITY   (China)

^c SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

^d SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Apoptosis; Cellular uptake; Nanoparticles; Selenium; Sialic acid

Indexed keywords

APOPTOSIS; APOPTOSIS-INDUCING ACTIVITY; APOPTOTIC; CANCER CELL APOPTOSIS; CANCER-TARGETING; CASPASE-3; CELL POPULATIONS; CELLULAR UPTAKE; CERVICAL CARCINOMA; DOSE-DEPENDENT; HELA CELL; MOLECULAR MECHANISM; MONODISPERSE; OPTIMIZED CONDITIONS; SELENIUM NANOPARTICLES; SIALIC ACIDS; SIMPLE METHOD; SURFACE DECORATION;

CARBOXYLIC ACIDS; CELL CULTURE; CELL PROLIFERATION; NANOPARTICLES; SELENIUM;

CELL DEATH;

CASPASE 3; NANOPARTICLE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SELENIUM NANOPARTICLE; SIALIC ACID; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOMA CELL; CELL POPULATION; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; DRUG TARGETING; DRUG UPTAKE; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MOLECULAR DYNAMICS; NANOFABRICATION; NANOMEDICINE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HELA CELLS; HUMANS; N-ACETYLNEURAMINIC ACID; NANOPARTICLES; SELENIUM; SURFACE PROPERTIES;

EID: 78650224859     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.11.023     Document Type: Article

References (18)

1. Nie S., Xing Y., Kim G.J., Simons J.W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 2007, 9:257-288.
2. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
3. Rozhkova E.A., Ulasov I., Lai B., Dimitrijevic N.M., Lesniak M.S., Rajh T. A high-performance nanobio photocatalyst for targeted brain cancer therapy. Nano Lett. 2009, 9:3337-3342.
4. Willmott L.J., Monk B.J. Cervical cancer therapy: current future and anti-angiogensis targeted treatment. Expert Rev. Anticancer Ther. 2009, 9:895-903.
5. Tao X., Hu W., Ramirez P.T., Kavanagh J.J. Chemotherapy for recurrent and metastatic cervical cancer. Gynecol. Oncol. 2008, 110:S67-S71.
6. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356:233-241.
7. Sinha R., El-Bayoumy K. Apoptosis is a critical cellular event in cancer chemoprevention and chemotherapy by selenium compounds. Curr. Cancer Drug Targets 2004, 4:13-28.
8. Wang H., Zhang J., Yu H. Elemental selenium at nano size possesses lower toxicity without compromising the fundamental effect on selenoenzymes: comparison with selenomethionine in mice. Free Radic. Biol. Med. 2007, 42:1524-1533.
9. Zhang J., Wang X., Xu T. Elemental selenium at nano size (Nano-Se) as a potential chemopreventive agent with reduced risk of selenium toxicity: comparison with Se-methylselenocysteine in mice. Toxicol. Sci. 2008, 101:22-31.
10. Chen T., Wong Y.S., Zheng W., Bai Y., Huang L. Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells. Colloids Surf. B: Biointerfaces 2008, 67:26-31.
11. Schauer R. Sialic acids as regulators of molecular and cellular interactions. Curr. Opin. Struct. Biol. 2009, 19:507-514.
12. Bondioli L., Costantino L., Ballestrazzi A., Lucchesi D., Boraschi D., Pellati F., Benvenuti S., Tosi G., Vandelli M.A. PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. Biomaterials 2010, 31:3395-3403.
13. Jayant S., Khandare J.J., Wang Y., Singh A.P., Vorsa N., Minko T. Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment. Pharm. Res. 2007, 24:2120-2130.
14. Chen T., Wong Y.S. Selenocystine induces apoptosis of A375 human melanoma cells by activating ROS-mediated mitochondrial pathway and p53 phosphorylation. Cell. Mol. Life Sci. 2008, 65:2763-2775.
15. Chen T., Wong Y.S. Selenocystine induces caspase-independent apoptosis in MCF-7 human breast carcinoma cells with involvement of p53 phosphorylation and reactive oxygen species generation. Int. J. Biochem. Cell Biol. 2009, 41:666-676.
16. Peer D., Karp J.M., Hong S., Farokhzad O.C., Margalit R., Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2:751-760.
17. Oliver F.J., de la Rubia G., Rolli V., Ruiz-Ruiz M.C., de Murcia G., Murcia J.M. Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J. Biol. Chem. 1998, 273:33533-33539.
18. Riedl S.J., Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 2004, 5:897-907.